Order
2093-04-1
1,1,1,3,3,3-Hexafluoro-2-(4-(4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenoxy)phenyl)-2-propanol
Order
20926-64-1
5-methyl-N-[3-(methylsulfanyl)phenyl]-5-nitro-1,3,2-dioxaphosphinan-2-amine 2-oxide
Order
209249-32-1
b-D-Glucopyranoside,(1aS,1bS,2S,5aR,6S,6aS)-6-[[6-deoxy-2,4-bis-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-a-L-mannopyranosyl]oxy]-1a,1b,2,5a,6,6a-hexahydro-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl
Order
20926-63-0
5-methyl-N-[2-(methylsulfanyl)phenyl]-5-nitro-1,3,2-dioxaphosphinan-2-amine 2-oxide
209249-32-1,20925-31-9,209256-61-1,209257-75-0,20926-49-2,20926-57-2 Supplier | KINGPHARM.GROUP
CMO CDMO service. KINGPHARM.GROUP supply 209249-32-1,20925-31-9,209256-61-1,209257-75-0,20926-49-2,20926-57-2 and related compounds.
209256-61-1
20926-57-2
209249-32-1
20926-49-2
20925-31-9
209257-75-0